Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Relationship between immunoglobulin A1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in immunoglobulin A nephropathyAlfons Segarra Medrano, Andrea Muijsemberg, David Wimbury, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2025
Authors' Reply: Questions Regarding the Analysis of Long-Term Outcomes in Nephrotic SyndromeDavid Pitcher, Bruce Hendry, Alex Mercer, et al.
Kidney International|August 25, 2024
Targeting APRIL in the treatment of glomerular diseasesChee Kay Cheung, Jonathan Barratt, Richard Lafayette, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2022
Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 GuidelineBingxin Yu, Sufang Shi, Jicheng Lv, et al.
Kidney International|May 1, 2022
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Kidney International Reports|November 29, 2023
Targeting the Endothelin A Receptor in IgA NephropathyDonald E Kohan, Jonathan Barratt, Hiddo J L Heerspink, et al.
Nephron. Experimental Nephrology|February 28, 2004
Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosisBin Yang, A Meguid El Nahas, Marie Fisher, et al.
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
Kidney International|September 20, 2025
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), Brad H Rovin, Jonathan Barratt, et al.
Kidney International Reports|September 12, 2022
International Physicians Delphi Survey: Managing Patients With IgA NephropathyJürgen Floege, Jonathan Barratt, Rosanna Coppo, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Relationship between immunoglobulin A1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in immunoglobulin A nephropathyAlfons Segarra Medrano, Andrea Muijsemberg, David Wimbury, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2025
Authors' Reply: Questions Regarding the Analysis of Long-Term Outcomes in Nephrotic SyndromeDavid Pitcher, Bruce Hendry, Alex Mercer, et al.
Kidney International|August 25, 2024
Targeting APRIL in the treatment of glomerular diseasesChee Kay Cheung, Jonathan Barratt, Richard Lafayette, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2022
Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 GuidelineBingxin Yu, Sufang Shi, Jicheng Lv, et al.
Kidney International|May 1, 2022
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Kidney International Reports|November 29, 2023
Targeting the Endothelin A Receptor in IgA NephropathyDonald E Kohan, Jonathan Barratt, Hiddo J L Heerspink, et al.
Nephron. Experimental Nephrology|February 28, 2004
Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosisBin Yang, A Meguid El Nahas, Marie Fisher, et al.
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
Kidney International|September 20, 2025
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), Brad H Rovin, Jonathan Barratt, et al.
Kidney International Reports|September 12, 2022
International Physicians Delphi Survey: Managing Patients With IgA NephropathyJürgen Floege, Jonathan Barratt, Rosanna Coppo, et al.
Pageof 28